Samsung Medical Center
Samsung Medical Center
Corea del Sud, Seul
Ki Woong Sung
28 anni di esperienza
Clinica certificata da :
| Corea del Sud | Turchia | Austria | |
| Terapia con cellule CAR-T | da $385,000 | da $150,000 | da $350,000 |
| Chemioterapia per la leucemia | da $22,000 | da $8,000 | da $15,000 |
| Chemioterapia per carcinoma mammario | da $19,200 | da $1,200 | da $15,000 |
| Aferesi terapeutica | - | da $1,350 | - |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Leucemia. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Leucemia e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Leucemia.
Il medico è il Direttore del Centro Oncologico Yonsei presso il Sistema Sanitario dell'Università Yonsei a Seul, Corea del Sud. Specializzato nel trattamento del cancro gastrico avanzato, il medico ha una vasta esperienza in chirurgia, oncologia e gastroenterologia.<\/p>
Il medico ha ricoperto posizioni prestigiose come Presidente dell'Associazione Coreana del Cancro Gastrico e dell'Associazione Internazionale del Cancro Gastrico, e Presidente del Consiglio dell'Associazione Coreana del Cancro e della Società Chirurgica Coreana.<\/p>
Riconosciuto come un chirurgo eccezionale nella chirurgia del cancro gastrico, il medico ha ricevuto numerosi riconoscimenti, tra cui il Premio Accademico per il Cancro e il Premio Accademico Yuhan.<\/p>
Il medico è un pediatra con specializzazione nel trapianto di midollo osseo e nel trattamento dei tumori cerebrali. Laureato in Medicina, con un Master e un Dottorato presso l'Università Nazionale di Seoul, il medico ha una vasta esperienza sia nella pratica clinica che nella ricerca.<\/p>
L'esperienza professionale include il servizio come pediatra presso il Samsung Medical Center, Professore Assistente nel Dipartimento di Pediatria presso la Clinica Samsung e ricercatore presso il Centro Oncologico della Scuola di Medicina dell'Università dell'Indiana. Il medico ha ricoperto ruoli di leadership come Capo del Dipartimento di Oncologia Pediatrica presso l'Ospedale Samsung e attualmente è Capo del Dipartimento di Pediatria presso la Clinica Samsung.<\/p>
Il medico è un ematologo-oncologo altamente esperto con oltre 26 anni di esperienza nel campo. Specializzato nel trattamento del cancro del colon, dell'oncologia ematologica, dei mielomi e dei linfomi, il medico è competente in procedure avanzate come il trapianto di midollo osseo, inclusi i trapianti da donatori alternativi e non compatibili.<\/p>
Con un forte background accademico, il medico possiede un M.D. dal College of Medicine dell'Università Yonsei e un Ph.D. dal College of Medicine dell'Università Sungkyunkwan. Il medico è anche membro di numerose società professionali e ha contribuito al campo attraverso numerose pubblicazioni di articoli.<\/p>
Samsung Medical Center, Seoul National University Hospital, and Asan Medical Center lead South Korea in leukemia treatment. These JCI-accredited facilities specialize in advanced cell therapies and hematopoietic stem cell transplants. They consistently rank among the top global oncology centers for hematologic malignancy outcomes.
Bookimed Expert Insight: Patient volume often signals where practitioners see the most complex cases. Severance Hospital treats 4,000,000 patients annually and manages 3,700 beds. This high turnover suggests local surgeons maintain peak proficiency in performing frequent, high-stakes leukemia procedures.
Patient Consensus: Patients emphasize finding hospitals with English-speaking hematologists and JCI status. They note that leukemia care often requires months-long stays and careful budget planning for translation.
Advanced cellular therapies like CAR T-cell are available for leukemia patients in South Korea. Facilities like Samsung Medical Center and Severance Hospital utilize these treatments. Kymriah is currently approved for relapsed B-cell acute lymphoblastic leukemia. Specialist centers in Seoul use advanced Good Manufacturing Practice facilities.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and maintains presidential health standards. This massive volume allows their Comprehensive Cancer Center to integrate technologies like Novalis into multi-modal leukemia protocols. This infrastructure is vital because CAR T-cell therapy requires highly specialized cell processing centers often only found in such large academic institutions.
Patient Consensus: Patients note that reaching these high-volume centers in Seoul provides peace of mind. They appreciate the clear, multidisciplinary approach where hematologists and cell specialists work together throughout the process.
International leukemia patients in Republic of Korea receive support through specialized centers accredited by KOIHA and JCI. Services include English-speaking coordinators, visa assistance, and digital health systems for error-free care. Major Seoul facilities provide medical interpreters to ensure clear instructions for complex protocols like CAR T-cell therapy.
Bookimed Expert Insight: High-volume centers like Severance and Samsung Medical Center handle millions of patients annually. Data shows that hospitals with GHA accreditation, such as SNUBH, offer superior logistics for international travelers. Patients should prioritize facilities that provide digital health tracking to ensure seamless post-treatment follow-ups.
Patient Consensus: Patients note that while hospitals provide coordinators, it is helpful to use apps like Papago for daily communication. Many recommend organizing long-term housing early, as leukemia therapy often requires several months near the clinic.
Foreign patients undergoing medical stem cell transplants for leukemia typically stay in South Korea for 1 to 3 months. Initial hospitalization for cell engraftment lasts 3 to 5 weeks. Patients must remain nearby for another 1 to 2 months for monitoring at specialized centers.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and maintains presidential standards. This high volume allows for specialized monitoring infrastructure. Patients at such large centers often benefit from integrated diagnostic suites including cytogenetic studies. High patient capacity suggests refined protocols for managing the long recovery journey.
Patient Consensus: Patients note that the language barrier is manageable through clinic coordinators. They also emphasize that staying in Seoul after discharge is necessary for frequent blood tests.
South Korean hematologists use bone marrow aspiration, high-sensitivity flow cytometry, and next-generation sequencing (NGS) to guide leukemia therapy. These tests identify specific mutations like FLT3 or BCR-ABL1. Results dictate the use of targeted drugs, immunotherapy, or CAR T-cell therapy protocols.
Bookimed Expert Insight: The depth of diagnostic infrastructure in Seoul is exceptional, shown by clinics like Asan Medical Center and Severance Hospital managing millions of patients. These high-volume centers integrate the BESTcare digital system or presidential-grade equipment to prevent errors in fast-paced NGS reporting. Patients benefit because these institutions handle the highest cancer volumes, ensuring molecular results are interpreted with massive comparative data sets.
Patient Consensus: Patients emphasize requesting full genetic panels immediately at diagnosis to avoid missing targeted treatment windows. They also recommend obtaining raw reports to ensure all mutations are cross-checked against global databases.
Haploidentical transplants are widely available as a standard option in South Korea for patients lacking full-matched donors. This method uses a 50% genetic match from parents, children, or half-matched siblings. Specialized centers in Seoul report survival rates comparable to fully matched transplants.
Bookimed Expert Insight: South Korea has transitioned into a global leader for mismatched transplants. Data shows Asan Medical Center reports a 90% success rate for organ transplants. This expertise extends to hematology, where specialized protocols allow for faster engraftment. Patients should note that Samsung Medical Center and Severance Hospital often manage high international volumes. These centers offer streamlined donor testing that is significantly faster than European or American registries.
Patient Consensus: Patients mention that finding a half-match from a biological child is a viable and successful route. Many emphasize the importance of starting testing early to speed up the process.
Bone marrow transplant services in South Korea are highly specialised and recognised worldwide. Major Seoul facilities, such as Samsung Medical Center and Asan Medical Center, routinely handle complex leukaemia cases. These institutions use CAR T-cell therapy and digital systems to maintain success rates near 90%.
Bookimed Expert Insight: Many countries have high-volume centres. However, South Korea stands out for tech-driven safety. Asan Medical Center performs 65,000+ operations annually. The BESTcare digital system across major Seoul clinics further reduces medical errors during leukaemia recovery.
Patient Consensus: Patients value the efficient digital record systems and JCI-accredited facilities in Seoul. The availability of intensive chemotherapy and CAR T-cell options provides confidence for complex leukaemia diagnoses.
Hospitals in the Republic of Korea offer leukaemia treatments including CAR-T therapy, such as Kymriah and Yescarta. Specialist centres report 70-90% efficacy for specific blood cancers. Leading Seoul hospitals provide these cell-based immunotherapies alongside bone marrow transplants and digital diagnostic protocols.
Bookimed Expert Insight: Many countries offer CAR-T therapy. However, Seoul hospitals like Severance and Samsung Medical Center treat massive volumes. Severance alone sees 4,000,000 patients annually. This scale allows departments to specialise in rare leukaemia subtypes. Smaller regional hospitals elsewhere may rarely see these cases.
Patient Consensus: Patients value the high-quality infrastructure in the Republic of Korea. They emphasise the need to confirm if CAR-T is available for specific subtypes before travelling.
Top South Korean hospitals for leukaemia care include Samsung Medical Center, Asan Medical Center, and Severance Hospital. These centres hold JCI and KOIHA accreditations. They offer therapies like CAR T-cell and stem cell transplants. Seoul National University Hospital also provides leading onco-haematology services.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital have the scale to treat millions of patients. This volume is a critical safety signal. It means haematology teams handle rare leukaemia subtypes and transplant complications daily.
Patient Consensus: Patients recommend large academic centres in Seoul for their specialist haematology-oncology teams. These units also provide vital intensive-care support. When travelling from Australia, choose hospitals with dedicated international coordinators. They help manage complex bone marrow transplant pathways and English-language communication.
Major South Korean hospitals provide English-language support for international leukaemia patients. Facilities like Severance Hospital and Ewha Womans University Medical Center employ English-speaking coordinators. Medical interpreters assist with complex protocols like CAR T-cell therapy and chemotherapy.
Bookimed Expert Insight: South Korea ranks fifth globally for medical requests on our platform. Leukaemia patients find the best support at digitalised centres. Seoul National University Bundang Hospital was the first fully digital hospital there. This technology reduces medical errors during complex haematology treatments. It also makes sharing records with Australian GPs much easier.
Patient Consensus: Patients find that international centres in Seoul provide smooth communication. They appreciate how coordinators handle logistics and explain medical steps clearly during treatment.